Patent · US Active

Crystalline forms of compositions comprising psilocin and psilocybin

US12351554B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 13, 2024
Grant dateJul 8, 2025
Priority date
Expiry dateJun 13, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present disclosure provides a composition comprising crystalline forms A, B, and C of psilocin and psilocybin. Solvent screen, X-ray powder diffractogram, thermogravimetric mass spectroscopy, differential scanning calorimetry, 1H-NMR, dynamic vapor sorption, and UPLC data on each of the crystalline forms is presented, along with methods preparing each of the crystalline forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.